On the contrary, pharmacological SGLT2:SGLT1 selectivity ratio significantly correlated with stroke outcomes, with lower SGLT2 selectivity (i.e. more pronounced inhibitory effect on SGLT1) corresponding with reduced risk. Here, SLC5A2 is linked to stroke disorder.